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Introduction: Sleepiness is one of the cardinal complaints of patients in tertiary referral
centres for sleep disorders. It is commonly associated with sleep disorders, but the additional
influence of obesity remains unclear. We hypothesised that obesity may be an independent
predictor of sleepiness in this population.
Patients and methods: We reviewed 335 patients undergoing overnight polysomnography over
a 3 month period (MayeJuly 2011), recording selected sleep parameters in addition to subjec-
tive sleepiness as measured by the Epworth Sleepiness Scale (ESS, 0e24 points).
Results: 173 patients (120 male, age 52 (13) years, BMI 33.9 (7.4) kg/m2) had obstructive sleep
apnoea and 59 of those were established on continuous positive airway pressure (CPAP). 55
patients (38 male, age 56 (14) years, BMI 31.7 (6.7) kg/m2) had PLM disorder, with 3 on medical
treatment. 155 patients were obese (93 male, age 50 (14) years, BMI 37.3 (6.1) kg/m2) and this
group was significantly sleepier than the 180 non-obese subjects (107 male, age 42 (15) years,
BMI 25.3 (3.0) kg/m2). The mean ESS of the obese group was 12.9 (5.5) points, compared to
10.4 (5.7) points for the non-obese patients (p < 0.001). Those with a diagnosis of OSA had
an ESS of 12.3 (5.8) versus 10.7 (5.7) points for those without (p Z 0.007). Females had an
ESS of 12.8 (5.9) compared to 10.7 (5.5) points for male patients (p < 0.001). Regression anal-
ysis revealed that obesity (pZ 0.007), PLM disorder (pZ 0.010) and hypertension (pZ 0.032)
were independently associated with subjective sleepiness (adjusted R2 Z 0.384, p Z 0.02),
obesity accounting for 15.7% of the variability in sleepiness.
Conclusion: Independent of underlying sleep disorders, obesity contributes significantly to
daytime sleepiness. Measures to promote weight loss and close links to a dietician assisted
service will be helpful in the specialist setting of a sleep disorders service to improve long-
term health outcomes.
ª 2012 Elsevier Ltd. All rights reserved.iratory Unit/Sleep Disorders Centre, Guy’s and St Thomas’ NHS Trust, London, UK.
.ac.uk (G. Slater).
2 Elsevier Ltd. All rights reserved.
2.10.013
306 G. Slater et al.BackgroundExcessive daytime sleepiness (EDS) is a common complaint,
with as many as 40% of the general population estimated to
suffer from some form of abnormal sleepiness at some
stage in their lives.1 It is the most common presenting
complaint in the Sleep Disorders Centre, with obstructive
sleep apnoea (OSA) and periodic limb movement disorder
(PLMD) frequently cited as the underlying diagnoses.
However, for many patients seen in tertiary referral
centres, treatment of the underlying condition may not
entirely treat their symptoms,2 suggesting that there are
other important factors contributing to hypersomnolence.
Additionally, it remains uncertainwhat factors contribute
to the severity of sleepiness symptoms in patients with OSA.
The apnoeaehypopnoea index (AHI) used to describe sleep-
disordered breathing and measure the severity of OSA does
not correlate well with the presence or degree of hyper-
somnolence. However, the relative success of continuous
positive airway pressure (CPAP) treatment in relieving EDS
suggests that the correction of intermittent nocturnal
hypoxaemia can improve symptoms. Despite this, studies
examining the significance of intermittent nocturnal hypoxia
have produced conflicting results.2e4
Obesity has been linked to EDS in the general pop-
ulation, even in the absence of sleep-disordered breath-
ing.5e7 Similarly, diet and food intake may contribute.8 It
has been suggested that EDS in obesity is a result of
systemic metabolic changes, which disrupt normal sleep
regulation.9
However, data on the significance of obesity in the
setting of the sleep disorder clinic with multiple different
diagnoses is currently lacking. We hypothesised that obesity
is a significant contributing factor to excess daytime
sleepiness in this patient population, independent of
underlying co-existing sleep disorder.
Methods and patients
This study reviewed patients undergoing overnight poly-
somnography during a three month period (MayeJuly 2011)
in the Sleep Disorders Centre at Guy’s & St Thomas’ NHS
Foundation Trust, London, UK. It was approved by the local
service board (project number 2011/2402). Age, gender and
body mass index (BMI) of each patient were recorded, along
with significant co-morbidities and medications. Daytime
sleepiness, as measured by the Epworth Sleepiness Scale
(ESS), was assessed. In the sleep study, we recorded sleep
latency (from a single night polysomnography),
apnoeaehypopnoea index (AHI) and periodic limb move-
ment (PLM) index. Technicians in our sleep laboratory
follow AASM guidelines to ensure standardisation of sleep
latency measurement during polysomnography (lights out
to first epoch of any sleep in minutes).10 In patients who
had undergone the multiple sleep latency test we included
a formal mean sleep latency (MSL) time. Data on co-
morbidities was obtained from the patients’ notes
(ischaemic heart disease, diabetes mellitus, heart failure
and depression). Patients with a diagnosis of narcolepsy
were excluded, as this contributes to daytime sleepiness
independently of BMI.Epworth sleepiness score
The ESS is used as a subjective measure of daytime sleep-
iness. Patients answer a self-administered questionnaire, in
which they rate how likely they are to fall asleep in eight
everyday situations. Each item is scored from 0 (not at all)
to 3 (very likely), allowing for a range of 0e24 points for
a total score (increasing scores indicate more severe
sleepiness). Total scores of more than 10 points are
considered excessively sleepy and commonly used as
a marker of pathological hypersomnolence,11 with a high
accuracy of identifying pathological sleepiness.12 The test
has a good internal and re-test reliability over 5 months.13
Polysomnography
Records from overnight polysomnography studies at St
Thomas’ Hospital were used to identify the sleep latency,
AHI and PLM index for each subject, as well as the MSL
where available. In this study, “sleep latency” refers to the
sleep latency time available from a single polysomnography
study for each patient, and MSL time refers to the result
from a formalised mean sleep latency test.10 The AHI
measures the number of apnoeas and hypopnoeas per hour
of sleep. Apnoeas greater than 10 s in duration are
considered clinically significant and were recorded by
measuring nasal and oral airflow and pressure. Obstructive
apnoeas are associated with ongoing respiratory muscle
effort, whilst central apnoeas are not. Hypopnoeas are
caused by respiratory obstructions, where there is a greater
than 50% reduction in airflow associated with a drop in
blood oxygen saturation.14 An AHI of 5/hour or more was
used as the cut off for classifying patients as having OSA.
Where available, the MSL score was recorded. During pol-
ysomnography, electrodes on the limbs were used to record
electromyographic activity of the muscles and identify
periodic limb movements.
Multiple sleep latency test
The mean sleep latency is derived from the multiple sleep
latency test, in which subjects take successive naps at 2 h
intervals. Polysomnographical recording is used to assess
the mean time to sleep onset for each nap, with an mean
sleep latency of less than 10 min considered abnormal, an
mean sleep latency of less than 5 min qualifies as severe
sleepiness.14 The mean sleep latency recorded from an
MSLT is an objective measure of sleepiness, whereas the
ESS provides a subjective assessment of symptoms. In this
study, a formal mean sleep latency from an MSLT was
available for 68 patients.
Statistical analysis
Initial analysis revealed that ESS and sleep latency scores
were not normally distributed and, thus, characteristics
between groups were compared using the ManneWhitney U
test. Spearman’s rank correlations were used to assess the
significance of age, BMI, AHI, oxygen desaturation index
(ODI) and PLM index on daytime sleepiness. Finally, the
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sleepiness was examined using multiple linear stepwise
regression analysis. The level of significance was chosen at
p < 0.05, data are presented as mean (standard deviation,
SD) for normally distributed parameters and as median
(interquartile range, IR) for non-normally distributed data.
Results
We studied 335 patients (200 male, age 46 (15) years, BMI
30.9 (7.6) kg/m2), of which 173 patients (52%) had obstruc-
tive sleep apnoea (120 male, age 52 (13) years, BMI 33.9
(7.4) kg/m2). 61 of those with sleep apnoeawere established
on continuous positive airway pressure (CPAP) therapy. 55
patients (16%) had PLM disorder (38 male, age 56 (14) years,
BMI 31.7 (6.7) kg/m2), with 3 on medical treatment (dopa-
minergic medication). A total of 200 patients (60%) were
classed as excessively sleepy (106 male, age 46 (15) years,
BMI 31.5 (7.6) kg/m2) and 135 (40%) as non-sleepy (94 male,
age 46 (15) years, BMI 29.9 (7.6) kg/m2). 111 patients in the
excessively sleepy group had OSA (56% of that group), whilst
62 (46%) of the non-sleepy patients had OSA (pZ 0.209). 31
(16%) of the sleepy group had PLMD versus 24 (18%) of the
non-sleepy group (pZ n.s., Table 1).
Within the excessively sleepy group, 38 patients were
diagnosed with hypertension, 36 with depression, 18 with
diabetes, 11 with asthma, 6 with ischaemic heart disease
and 1 with chronic heart failure. In the non-sleepy group,
21 patients had a diagnosis of hypertension, 13 of depres-
sion, 6 of diabetes, 11 of asthma and 7 of ischaemic heart
disease (Table 1).Table 1 Patient characteristics, p-value indicating level of sign
group. The only significant difference between the groups was B
Characteristic All (n Z 335) ESS 
(n Z
mean
Male 200 94
Age (years) 46 (15) 46 (1
BMI (kg/m2) 30.9 (7.6) 29.9
Obese 155 51
PLM index 9.0 (21.2) 9.4 (
ODI hr1 10.0 (13.6) 8.4 (
AHI hr1 9.4 (15.3) 7.9 (
Arousal index 13.1 (7.4) 13.4
TST 357.8 (72.7) 354.5
Sleep efficiency 77.1 (14.8) 77.3
1 Co-morbidity 101 30
Depression 49 13
Diabetes mellitus 24 6
Ischaemic heart disease 13 7
Hypertension 59 38
Heart failure 1 0
ESS: Epworth sleepiness score.
BMI: body mass index.
PLM: periodic limb movement.
ODI: oxygen desaturation index.
AHI: apnoeaehypopnoea index.
TST: total sleep time.In total, 155 patients (46%) were obese (93 male, age 50
(14) years, BMI 37.3 (6.1) kg/m2) and this group scored
significantly higher than the 180 non-obese (53.7%) subjects
(107 male, age 42 (15) years, BMI 25.3 (3.0) kg/m2).
Factors affecting ESS
Patients with a diagnosis of OSA had significantly higher ESS
scores than those without, and female patients had signif-
icantly higher scores than males. There was no difference
in sleepiness between patients with or without PLMD. The
factor which differed significantly between the sleepy and
non-sleepy patients was BMI (p Z 0.016) (online supple-
ment, Table E1).
There was a low but significant correlation between BMI
and ESS (r Z 0.236, p < 0.001) (Table 2). Factors signifi-
cantly correlated with the sleep latency time were BMI
(rZ 0.242), AHI (rZ 0.326), ODI (rZ 0.229) and PLM
index (r Z 0.280: p < 0.001, respectively).
We performed a linear regression analysis, entering
variables in a stepwise model. The variables included were
age, gender, BMI, obesity (as a binary variable), sleep
latency, mean sleep latency (from a formal MSLT, where
available), AHI, OSA (as a binary variable) and the presence
of at least one significant co-morbidity. The co-morbidities
included in the analysis were hypertension, ischaemic heart
disease, heart failure, diabetes, asthma and depression.
The factors found to be independently associated with ESS
were obesity (p Z 0.007), PLM disorder (p Z 0.010) and
hypertension (pZ 0.032). It is of note that the presence or
absence of obesity as a binary variable was an independentificance between sleepy (ESS > 10) and non-sleepy (ESS  10)
MI.
10
135,
ESS Z 5.6)
ESS > 10
(n Z 200,
mean ESS Z 15.5)
p-Value
106
5) 46 (15) 0.807
(7.6) 31.5 (7.6) 0.021
104
21.2) 8.8 (21.2) 0.926
12.5) 11.1 (14.2) 0.109
11.8) 10.4 (17.3) 0.645
(5.8) 12.9 (8.3) 0.062
(70.7) 360.0 (74.2) 0.498
(14.6) 77.0 (15.0) 0.957
71
36
18
6
21
1
Table 2 Spearman’s rank correlation coefficients. Significant correlations were found between ESS and BMI (**p < 0.001), ODI
(p Z 0.018) and PLMD (p Z 0.032). *p < 0.05.
ESS Age BMI AHI ODI PLMD
ESS Correlation coefficient 0.035 0.236** 0.091 0.139* 0.117*
Age Correlation coefficient 0.035 0.264** 0.358** 0.318** 0.143**
BMI Correlation coefficient 0.236** 0.264** 0.393** 0.450** 0.079
AHI Correlation coefficient 0.091 0.358** 0.393** 0.883** 0.013
ODI Correlation coefficient 0.139* 0.318** 0.450** 0.883** 0.004
PLMD Correlation coefficient 0.117* 0.143** 0.079 0.013 0.004
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accounted for approximately 38.4% of the variability in the
Epworth sleepiness score (adjusted R2 Z 0.384, p Z 0.02),
with obesity accounting for 15.7%, PLM disorder for 12.3%
and hypertension for 10.8%.
A further multivariate stepwise model was produced to
exclude those patients with a pre-existing diagnosis of
cardiovascular disease (hypertension, ischaemic heart
disease and heart failure), as this is frequently associated
with BMI. This model included 273 patients (164 male, age
43 (14) years, BMI 29.7 (6.9) kg/m2) and assessed the same
variables as the previous regression analysis. In this model,
only the ODI was found to be independently associated with
ESS (adjusted R2 Z .093, p Z 0.02).
Of the 155 obese patients, 68 had at least one significant
co-morbidity. A ManneWhitney U test was performed to
compare the ESS between obese patients with or without
significant co-morbidities. There was no difference in
sleepiness between those with none of these diseases
(n Z 87, ESS 13.0 (5.7)) and those who had at least one
(n Z 68, ESS 12.7 (5.4), p Z 0.977).
61 of the 173 patients with OSA were established on
CPAP at the time of their polysomnography study. 39 of
these patients still had an ESS > 10. Of the 55 patients with
PLMD, 3 were on medication for this disorder. All three
PLMD patients had an ESS > 10 and were also established on
CPAP. The stepwise multivariate regression analysis was
repeated, excluding the patients treated with CPAP or
PLMD medications. The resulting model included 274
patients (152 male, age 45 (15), BMI 30.1 (7.2) kg/m2).
Independent predictors of ESS in this model were obesity
(p < 0.001), female gender (p Z 0.022) and PLMD
(p Z 0.034). This model accounted for 8.3% of the vari-
ability in sleepiness in this population, with obesity alone
accounting for 5.4%.
Objective measures of sleepiness
The sleep latency from each polysomnography study was
available; this was not found to correlate significantly with
the ESS (R2 Z 0.01, p Z 0.25; online supplement, Fig. E1).
However, the sleep latency from individual poly-
somnography studies correlated with the mean sleep
latency from the MSLT (correlation coefficient 0.441,
p < 0.001). Stepwise linear regression analysis showed that
only AHI independently predicted the objective sleep
latency (adjusted R2 of 0.116, p Z 0.042). There were
significant differences in the sleep latency between obese
and non-obese, male and female, OSA and non-OSApatients and those with or without PLM disorder. No
difference in sleep latency was found between groups
assessed as sleepy or non-sleepy on the basis of ESS (online
supplement, Table E2).
In the 68 patients for whom a formal MSLT result was
available, obese patients (n Z 22) had a mean sleep
latency of 8.8 (4.9) min and non-obese patients (n Z 46)
had an MSL of 11.8 (7.5) min (p Z 0.085).
Discussion
Obesity contributes significantly to daytime sleepiness
independent of underlying sleep-disordered breathing
(SDB). We found that obesity accounts for approximately
16% of the variation in subjective daytime sleepiness; in
conjunction with other co-morbidities such as PLMD and
hypertension it explains 38% of the variation in sleepiness.
An elevated AHI or ODI did not contribute independently to
subjective daytime sleepiness.
Although the presence or absence of obesity as a binary
variable was found to predict ESS, BMI as a continuous
variable did not. There was no significant difference in
sleepiness between obese patients with or without serious
co-morbidities and obesity remained the single most
important variable determining ESS when patients estab-
lished on CPAP were removed from the model. This further
emphasises the importance of obesity in this patient pop-
ulation. We excluded patients with significant cardiovas-
cular disease for a sub-analysis due to the recognised
association of this condition with an increased BMI.7 In this
model only ODI was found to independently predict ESS.
This may suggest that obesity is the most important factor
determining sleepiness in patients who are otherwise
healthy.
Our findings are consistent with a number of other
studies, which have identified a link between obesity and
hypersomnolence that is independent of underlying sleep-
disordered breathing. Polysomnographic studies of obese
patients awaiting bariatric surgery have shown that AHI is
not predictive of the severity of sleepiness encountered in
this group.15 Within a group of OSA patients, obesity and
depressive symptoms have been described to be predictive
of ESS score whilst AHI was not, suggesting that the severity
of OSA is not the most important contributor to excessive
daytime sleepiness.16
A number of mechanisms have been suggested which
may account for increased sleepiness in the obese pop-
ulation without underlying sleep disorders.8,17 It is possible
that some of the patients in this study may have
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is defined as the presence of daytime hypercapnia
(PaCO2 > 45 mmHg/6 kPa) in an obese subject in the
absence of other causes of hypoventilation, with significant
sleep-disordered breathing by night. In contrast, OSA
patients usually do not experience hypoxia or hypercapnia
during the day.18 Consequently, OHS patients are more
likely to experience hypersomnolence than matched OSA
patients.19 Another potential pathway in such patients is
that the metabolic disruption associated with obesity,
including increased levels of insulin and pro-inflammatory
cytokines, diet and food intake is responsible for
increased daytime sleepiness.8,9
Most of the patients with a diagnosis of OSA in our study
were established on CPAP, so the results must be inter-
preted with caution. Additionally, whilst ESS is a reliable
indicator of excessive daytime sleepiness, it did not
correlate with objective measures of sleepiness. The lack
of correlation between the subjective and objective
measures of sleepiness, as previously demonstrated by
Kingshott et al.,20 demonstrates the difficulties in accu-
rately assessing the severity of this symptom, making it
difficult to provide evidence-based guidance to treat it
consistently. Furthermore, it emphasises the importance of
patient-based outcomes and develop more reliable objec-
tive tests of relevant patient symptoms.Conclusion
Obesity contributes significantly to excessive daytime
sleepiness of patients independently of sleep-disordered
breathing. As a result, the provision of weight-loss
promoting measures and close links to a dietician in
a sleep disorders centre will be required to improve long-
term health outcomes. However, multiple candidate
factors currently explain excessive daytime sleepiness only
to some extent; neither do objective measures of sleepi-
ness correlate well with subjective symptoms. This indi-
cates an ongoing lack of understanding of the
pathophysiology behind this common symptom and the
need to identify other contributing factors.Appendix A. Supplementary data
Supplementary data related to this article can be found
online at http://dx.doi.org/10.1016/j.rmed.2012.10.013.Conflict of interest statement
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